Feasibility of [
FAPI
Fibroblast activating protein
Metastatic urothelial carcinoma
PET/CT imaging
Urothelial carcinoma
Journal
European journal of nuclear medicine and molecular imaging
ISSN: 1619-7089
Titre abrégé: Eur J Nucl Med Mol Imaging
Pays: Germany
ID NLM: 101140988
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
received:
31
01
2022
accepted:
11
03
2022
pubmed:
25
3
2022
medline:
27
7
2022
entrez:
24
3
2022
Statut:
ppublish
Résumé
[ Fifteen patients with UC prior to or after local treatment underwent [ Overall, 64 tumor sites were detected on PET and/or CT. The highest uptake intensity was noted at the primary site (SUV [
Sections du résumé
BACKGROUND
[
METHODS
Fifteen patients with UC prior to or after local treatment underwent [
RESULTS
Overall, 64 tumor sites were detected on PET and/or CT. The highest uptake intensity was noted at the primary site (SUV
CONCLUSION
[
Identifiants
pubmed: 35325283
doi: 10.1007/s00259-022-05761-5
pii: 10.1007/s00259-022-05761-5
pmc: PMC9308618
doi:
Substances chimiques
FAPI-46
0
Gallium Radioisotopes
0
Quinolines
0
Fluorodeoxyglucose F18
0Z5B2CJX4D
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3571-3580Informations de copyright
© 2022. The Author(s).
Références
J Nucl Med. 2018 Sep;59(9):1415-1422
pubmed: 29626119
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
J Nucl Med. 2021 Feb;62(2):201-207
pubmed: 32591493
Curr Opin Chem Biol. 2021 Aug;63:145-151
pubmed: 34004409
J Nucl Med. 2022 Jun;63(6):890-896
pubmed: 34620730
Eur Urol. 2021 Jan;79(1):62-79
pubmed: 32593530
Eur J Nucl Med Mol Imaging. 2020 Nov;47(12):2836-2845
pubmed: 32447444
J Nucl Med. 2022 May;63(5):727-734
pubmed: 34385340
J Int Bioethique. 2004 Mar;15(1):124-9
pubmed: 15835069
Eur Urol Focus. 2019 Jan;5(1):90-96
pubmed: 28753817
Radiographics. 2017 Mar-Apr;37(2):577-594
pubmed: 28287942
Eur Urol. 2020 Jun;77(6):727-732
pubmed: 30981590
Eur J Nucl Med Mol Imaging. 2022 Jan;49(2):721-731
pubmed: 34342669
Clin Cancer Res. 2012 Jun 15;18(12):3377-86
pubmed: 22553347
Cancers (Basel). 2019 May 20;11(5):
pubmed: 31137599
BJU Int. 2014 Jul;114(1):67-74
pubmed: 24053889
Nucl Med Rev Cent East Eur. 2014;17(2):83-6
pubmed: 25088107
World J Urol. 2016 Sep;34(9):1229-37
pubmed: 26847182
Ann Nucl Med. 2018 Jan;32(1):69-74
pubmed: 29067547
Eur J Nucl Med Mol Imaging. 2022 Feb;49(3):963-979
pubmed: 34410435
Cancers (Basel). 2021 Sep 30;13(19):
pubmed: 34638433
Eur Urol. 2014 Apr;65(4):778-92
pubmed: 24373477
Curr Oncol. 2011 Jan;18(1):e25-34
pubmed: 21331269
J Nucl Med. 2020 Aug;61(8):1171-1177
pubmed: 31836685
N Engl J Med. 2017 Mar 16;376(11):1015-1026
pubmed: 28212060
J Nucl Med. 2019 Mar;60(3):386-392
pubmed: 30072500
Hum Pathol. 2019 Sep;91:61-68
pubmed: 31279874
Clin Genitourin Cancer. 2017 Jun;15(3):e387-e395
pubmed: 27601364
Tumour Biol. 2015 May;36(5):3209-14
pubmed: 25809703
J Urol. 2004 May;171(5):1830-4
pubmed: 15076287
J Urol. 2013 Apr;189(4):1214-21
pubmed: 23023150